BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7213561)

  • 1. Factitious urticaria: red dermographism.
    Warin RP
    Br J Dermatol; 1981 Mar; 104(3):285-8. PubMed ID: 7213561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic dermographism.
    Mayou SC; Kobza Black A; Eady RA; Greaves MW
    Br J Dermatol; 1986 Sep; 115(3):371-7. PubMed ID: 3756094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and other aspects of factitious wealing (dermographism).
    Kirby JD; Matthews CN; James J; Duncan EH; Warin RP
    Br J Dermatol; 1971 Oct; 85(4):331-5. PubMed ID: 5125637
    [No Abstract]   [Full Text] [Related]  

  • 4. Immediate-pressure urticaria--a distinct disorder.
    Lawlor F; Kobza Black A; Greaves M
    Clin Exp Dermatol; 1991 May; 16(3):155-7. PubMed ID: 1934562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patients with symptomatic dermographism.
    Taşkapan O; Harmanyeri Y
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):58-62. PubMed ID: 16405609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermographism: a review.
    Wong RC; Fairley JA; Ellis CN
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 1):643-52. PubMed ID: 6386900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquagenic urticaria: evidence of cholinergic and histaminergic basis.
    Sibbald RG; Black AK; Eady RA; James M; Greaves MW
    Br J Dermatol; 1981 Sep; 105(3):297-302. PubMed ID: 7272209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UVB treatment of factitious urticaria.
    Johnsson M; Falk ES; Volden G
    Photodermatol; 1987 Dec; 4(6):302-4. PubMed ID: 3444755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic dermographism (factitious urticaria)--passive transfer experiments from human to monkey.
    Murphy GM; Zollman PE; Greaves MW; Winkelmann RK
    Br J Dermatol; 1987 Jun; 116(6):801-4. PubMed ID: 3620341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic dermographism.
    Margolis CF; Estes SA
    J Fam Pract; 1981 Dec; 13(7):993-5. PubMed ID: 6118390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular dermographism.
    Shelley WB; Shelley ED
    Cutis; 1983 Sep; 32(3):244-5, 254, 260. PubMed ID: 6627988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solar urticaria: a case with increased skin mast cells and good therapeutic response to an antihistamine.
    Rantanen T; Suhonen R
    Acta Derm Venereol; 1980; 60(4):363-5. PubMed ID: 6163290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold urticaria and cold precipitated dermographism.
    Matthews CN; Warin RP
    Br J Dermatol; 1970 Jan; 82(1):91. PubMed ID: 5410995
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythematous reactions on removal of Scanpor® tape in patch testing are not necessarily caused by dermographism.
    Sheraz A; Simms MJ; White IR; White JM
    Contact Dermatitis; 2014 Jul; 71(1):62-4. PubMed ID: 24924815
    [No Abstract]   [Full Text] [Related]  

  • 15. Dermographism secondary to trauma from a coral reef.
    Wu JJ; Huang DB; Murase JE; Weinstein GD
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1337-8. PubMed ID: 17062061
    [No Abstract]   [Full Text] [Related]  

  • 16. Factitious urticaria (dermographism): treatment by cimetidine and chlorpheniramine in a randomized double-blind study.
    Kaur S; Greaves M; Eftekhari N
    Br J Dermatol; 1981 Feb; 104(2):185-90. PubMed ID: 7011357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of astemizole and chlorpheniramine in dermographic urticaria.
    Krause LB; Shuster S
    Br J Dermatol; 1985 Apr; 112(4):447-53. PubMed ID: 3922395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solar urticaria. A case with possible increase of skin mast cells.
    Baart de la Faille H; Rottier PB; Baart de la Faille-Kuyper EH
    Br J Dermatol; 1975 Jan; 92(1):101-7. PubMed ID: 239738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic dermographism: wealing, mast cells and histamine are decreased in the skin following long-term application of a potent topical corticosteroid.
    Lawlor F; Black AK; Murdoch RD; Greaves MW
    Br J Dermatol; 1989 Nov; 121(5):629-34. PubMed ID: 2597634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism.
    Mlynek A; Vieira dos Santos R; Ardelean E; Weller K; Magerl M; Church MK; Maurer M
    Clin Exp Dermatol; 2013 Jun; 38(4):360-6; quiz 366. PubMed ID: 23621090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.